Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
Watch the replay of Axe Compute's Second Quarter 2026 earnings conference call, originally held live on Monday, August 17, 2026 at 8:30 a.m. Eastern Time. Christopher Miglino, Chief Executive Officer; Kyle Okamoto, President; and Jeremy Yaukey-Witter, Chief Financial Officer, review the Company's Q2 2026 financial results, recent business developments, and priorities for the second half of 2026. Key highlights discussed on the call: Revenue grew more than 90x sequentially in the Company's first full quarter of compute operations Customer prepayments grew from $0.8 million to $60.8 million, with $17.4 million in operating cash flow in the first half of 2026 The $260 million dedicated cluster of 2,304 NVIDIA B300 GPUs progressed through build, targeted for Q3 2026 go-live Total 2026 signed contracted value now exceeds $3 billion Read the full press release and financial statements on Axe Compute's investor website.
August 17, 2026
September 29, 2026
PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it launched its Japanese-language short drama “ドS社長と死にゆく奥様の百日戦争” on August 13th at FlexTV. The intense emotional confrontations in the drama are like sharp lancet blades, precisely dissecting the dark sides of the characters’ inner selves. This compels the audience […]
August 15, 2024
PITTSBURGH, Sept. 29, 2026 (GLOBE NEWSWIRE) — Axe Compute Inc. (NASDAQ: AGPU) today announced that it has received more than $184 million in customer prepayments and signed over $266 million in new AI infrastructure contracts since reporting second-quarter results on August 17, 2026. The prepayments, drawn from both newly signed agreements and existing contracts, represent capital […]
September 29, 2026
LITTLETON, Colo., Sept. 29, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (Nasdaq: VVOS), a medical device and healthcare services company focused on developing and commercializing diagnostic and treatment methods for patients with obstructive sleep apnea (“OSA”) and other breathing and sleep disorders, today announced execution by management on a restructuring and cost reduction […]
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026
September 29, 2026